Which heavily marketed arthritis drug was voluntarily withdrawn from the market in 2004 after being linked to increased risk of heart attacks and strokes?

The pharmaceutical industry has seen numerous high-profile product launches that ultimately failed despite significant investment in research, development, and marketing. These failures often occur due to unexpected side effects, regulatory issues, or market competition. Test your knowledge about one of the most notorious medical product launch failures in recent history!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Vioxx (rofecoxib) by Merck
Bextra (valdecoxib) by Pfizer
Celebrex (celecoxib) by Pharmacia
Humira (adalimumab) by Abbott